Invasive NSTEMI Strategy Shows No Benefit in Frail Patients - Poll - MDSpire

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

  • By

  • Kathryn Wighton

  • May 6, 2026

  • 4 min

Share

Original Source(s)

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

  • by Kathryn Wighton

  • May 6, 2026

Related Content

Therapeutic Targeting of Mitochondrial Dysfunction in Heart Failure: A Systematic Review & Meta-Analysis of Clinical Outcomes

Elevated angiography-derived microvascular resistance and HbA1c levels jointly predict adverse outcomes in patients with diabetic STEMI: a multicenter retrospective cohort study

Radiation Reduction Through the Use of a Novel Ultra-Low Dose Fluoroscopy Imaging Protocol in Congenital Cardiac Catheterization